Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Genflow Biosciences PLC - London-based biotechnology company - Enters into a research agreement with Magnitude Biosciences Ltd, a UK-based biotechnology research organisation focused on drug discovery and product development. The collaboration will accelerate Genflow's therapeutic developments. Company adds that it will put it ‘on track’ to carry out its research and pre-clinical drug discovery.
Current stock price: 2.59 pence, down 0.4% on Monday
12-month change: down 77%
Copyright 2022 Alliance News Limited. All Rights Reserved.